AstraZeneca PLC (GB:AZN)

AstraZeneca (AZN) Financial Statements


AstraZeneca Financial Overview

AstraZeneca's market cap is currently ―. The company's EPS TTM is p3.246; its P/E ratio is 37.28; and it has a dividend yield of 1.88%. AstraZeneca is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is p1.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 11.21B$ 10.98B$ 10.77B$ 11.39B$ 12.01B
Gross Profit$ 8.31B$ 8.00B$ 7.77B$ 7.88B$ 7.39B
EBIT$ 1.12B$ 1.26B$ 558.00M$ 889.00M$ -324.00M
EBITDA$ 2.38B$ 2.60B$ 1.92B$ 2.20B$ 1.87B
Net Income Common Stockholders$ 901.00M$ 1.64B$ 360.00M$ 386.00M$ -347.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.24B$ 4.90B$ 4.89B$ 5.82B$ 6.40B
Total Assets$ 96.48B$ 94.19B$ 96.58B$ 100.27B$ 105.36B
Total Debt$ 29.23B$ 29.30B$ 29.53B$ 31.10B$ 30.78B
Net Debt$ 22.99B$ 24.40B$ 24.64B$ 25.28B$ 24.38B
Total Liabilities$ 59.42B$ 59.03B$ 60.63B$ 63.91B$ 66.08B
Stockholders Equity$ 37.04B$ 35.13B$ 35.93B$ 36.34B$ 39.27B
Cash Flow-
Free Cash Flow$ 1.84B$ 1.82B$ 705.00M$ 2.87B$ 700.00M
Operating Cash Flow$ 2.40B$ 2.93B$ 1.25B$ 3.23B$ 1.42B
Investing Cash Flow$ -249.00M$ -1.74B$ -800.00M$ -168.00M$ -913.00M
Financing Cash Flow$ -358.00M$ -1.43B$ -1.29B$ -3.74B$ -1.05B
Currency in USD

AstraZeneca Earnings and Revenue History

AstraZeneca Debt to Assets

AstraZeneca Cash Flow

AstraZeneca Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis